[
  {
    "ts": "2025-10-30T22:30:02+00:00",
    "headline": "Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say",
    "summary": "Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finance.yahoo.com/news/gilead-gild-reports-q3-earnings-223002825.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "7c9e5c7d-0235-3311-b976-7f31b6e55fc8",
      "content": {
        "id": "7c9e5c7d-0235-3311-b976-7f31b6e55fc8",
        "contentType": "STORY",
        "title": "Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say",
        "description": "",
        "summary": "Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
        "pubDate": "2025-10-30T22:30:02Z",
        "displayTime": "2025-10-30T22:30:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619",
          "originalWidth": 900,
          "originalHeight": 506,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WMc9TPUzGnRwQQgeGPg3VQ--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619.cf.webp",
              "width": 900,
              "height": 506,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kbEpsaBWvOchoGFZ2uOESQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-reports-q3-earnings-223002825.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-reports-q3-earnings-223002825.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T21:15:02+00:00",
    "headline": "Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates",
    "summary": "Gilead (GILD) delivered earnings and revenue surprises of +14.88% and +4.16%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/gilead-sciences-gild-q3-earnings-211502785.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e4a9bc62-2d00-3306-a815-2cccbbe7f647",
      "content": {
        "id": "e4a9bc62-2d00-3306-a815-2cccbbe7f647",
        "contentType": "STORY",
        "title": "Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates",
        "description": "",
        "summary": "Gilead (GILD) delivered earnings and revenue surprises of +14.88% and +4.16%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2025-10-30T21:15:02Z",
        "displayTime": "2025-10-30T21:15:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba",
          "originalWidth": 900,
          "originalHeight": 745,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J2T_cDhaoaaQj0soPS_nNw--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 900,
              "height": 745,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sWMlcbg78JI.iCrZWAER9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-q3-earnings-211502785.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-q3-earnings-211502785.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:45:00+00:00",
    "headline": "Gilead Earnings Beat Expectations. The Stock Is Still Falling.",
    "summary": "Gilead  Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine.  Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June.  Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.",
    "url": "https://www.barrons.com/articles/gilead-earnings-stock-price-3f6378ed?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "a6db1552-53ac-36a2-8075-a1ec798bdd7d",
      "content": {
        "id": "a6db1552-53ac-36a2-8075-a1ec798bdd7d",
        "contentType": "STORY",
        "title": "Gilead Earnings Beat Expectations. The Stock Is Still Falling.",
        "description": "",
        "summary": "Gilead  Sciences reported third-quarter results that surpassed Wall Street expectations late Thursday, amid a close focus on the launch of the company’s promising new HIV medicine.  Gilead shares are up 30% this year, largely on enthusiasm for Yeztugo, a twice-yearly HIV prevention shot that the FDA approved in June.  Gilead said Thursday that sales of Yeztugo had been $39 million in the third quarter.",
        "pubDate": "2025-10-30T20:45:00Z",
        "displayTime": "2025-10-30T20:45:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a6db1552-53ac-36a2-8075-a1ec798bdd7d/gilead-earnings-beat.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/218caf9334da2a9768d2cb525cb7ee0e",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lxAbvrE0N.9JQxx77LMIOw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/218caf9334da2a9768d2cb525cb7ee0e.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QFeKSxOPTxwP4Wx0g8tz1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/218caf9334da2a9768d2cb525cb7ee0e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/gilead-earnings-stock-price-3f6378ed?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:28:20+00:00",
    "headline": "Gilead Sciences (NASDAQ:GILD) Exceeds Q3 Expectations",
    "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) announced better-than-expected revenue in Q3 CY2025, with sales up 3% year on year to $7.77 billion. On the other hand, the company’s full-year revenue guidance of $28.55 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $2.47 per share was 15.7% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-nasdaq-gild-exceeds-202820600.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "8c32503b-b88a-3d74-9703-5a9a61e7a7a0",
      "content": {
        "id": "8c32503b-b88a-3d74-9703-5a9a61e7a7a0",
        "contentType": "STORY",
        "title": "Gilead Sciences (NASDAQ:GILD) Exceeds Q3 Expectations",
        "description": "",
        "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) announced better-than-expected revenue in Q3 CY2025, with sales up 3% year on year to $7.77 billion. On the other hand, the company’s full-year revenue guidance of $28.55 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $2.47 per share was 15.7% above analysts’ consensus estimates.",
        "pubDate": "2025-10-30T20:28:20Z",
        "displayTime": "2025-10-30T20:28:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GILD Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7IhZSScYZ4CvnQJJpve_Dg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cv.0mSrHV7hG2Zeh2xc10A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-nasdaq-gild-exceeds-202820600.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-nasdaq-gild-exceeds-202820600.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:11:49+00:00",
    "headline": "Gilead: Q3 Earnings Snapshot",
    "summary": "GILD) on Thursday reported third-quarter earnings of $3.05 billion. On a per-share basis, the Foster City, California-based company said it had profit of $2.43. Earnings, adjusted for one-time gains and costs, came to $2.47 per share.",
    "url": "https://finance.yahoo.com/news/gilead-q3-earnings-snapshot-201149062.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "13d1ec47-c59b-3fd2-9e86-b1f32d036418",
      "content": {
        "id": "13d1ec47-c59b-3fd2-9e86-b1f32d036418",
        "contentType": "STORY",
        "title": "Gilead: Q3 Earnings Snapshot",
        "description": "",
        "summary": "GILD) on Thursday reported third-quarter earnings of $3.05 billion. On a per-share basis, the Foster City, California-based company said it had profit of $2.43. Earnings, adjusted for one-time gains and costs, came to $2.47 per share.",
        "pubDate": "2025-10-30T20:11:49Z",
        "displayTime": "2025-10-30T20:11:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-q3-earnings-snapshot-201149062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-q3-earnings-snapshot-201149062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:02:00+00:00",
    "headline": "Gilead Sciences Announces Third Quarter 2025 Financial Results",
    "summary": "FOSTER CITY, Calif., October 30, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-announces-third-quarter-200200377.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e48c859b-4067-301e-b948-376a136acb62",
      "content": {
        "id": "e48c859b-4067-301e-b948-376a136acb62",
        "contentType": "STORY",
        "title": "Gilead Sciences Announces Third Quarter 2025 Financial Results",
        "description": "",
        "summary": "FOSTER CITY, Calif., October 30, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations.",
        "pubDate": "2025-10-30T20:02:00Z",
        "displayTime": "2025-10-30T20:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/46ef7c3a20f762ea9c44d297784e6fb7",
          "originalWidth": 1728,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O6RiHB9DmSgk8CjKWvQq2Q--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/46ef7c3a20f762ea9c44d297784e6fb7.cf.webp",
              "width": 1728,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N0U5pN2ztlfcnScjPgn7tg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/46ef7c3a20f762ea9c44d297784e6fb7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-announces-third-quarter-200200377.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-announces-third-quarter-200200377.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-30T20:01:00+00:00",
    "headline": "Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development",
    "summary": "New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board Mechelen, Belgium; October 30, 2025, 21:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced several changes to its Board of Directors as part of its ongoing commitment to long-term governance and strategic continuity. These changes strengthen the alignment of the Board’s composition with the Company’s strategic direction and support its focus on transformational busin",
    "url": "https://finance.yahoo.com/news/galapagos-announces-changes-board-accelerate-200100732.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "2d5517d5-8f0c-31ac-b88e-8fefc5cbbbee",
      "content": {
        "id": "2d5517d5-8f0c-31ac-b88e-8fefc5cbbbee",
        "contentType": "STORY",
        "title": "Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development",
        "description": "",
        "summary": "New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board Mechelen, Belgium; October 30, 2025, 21:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced several changes to its Board of Directors as part of its ongoing commitment to long-term governance and strategic continuity. These changes strengthen the alignment of the Board’s composition with the Company’s strategic direction and support its focus on transformational busin",
        "pubDate": "2025-10-30T20:01:00Z",
        "displayTime": "2025-10-30T20:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/27744832f947e91d201e1a07d1998d59",
          "originalWidth": 5097,
          "originalHeight": 938,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/i1RKzhbTOQ0vhJTc5774gg--~B/aD05Mzg7dz01MDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/27744832f947e91d201e1a07d1998d59.cf.webp",
              "width": 5097,
              "height": 938,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BuWmhr.OspHqtmIAsZ7b3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/27744832f947e91d201e1a07d1998d59.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/galapagos-announces-changes-board-accelerate-200100732.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/galapagos-announces-changes-board-accelerate-200100732.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GLPG.AS"
            },
            {
              "symbol": "GLPG"
            },
            {
              "symbol": "GLPGF"
            },
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]